Inflammatory Pseudotumor After Liver Transplantation

Lykavieris, Panayotis; Fabrè, Monique; Waguet, J.; Bernard, O.

doi:10.1097/00005176-200009000-00021

Cited by 18 publications

(19 citation statements)

References 9 publications

(15 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Recently, cases of inflammatory pseudotumor in association with transplantation have been successively reported although it is a rare condition. To our knowledge, only four cases of IMT after solid-organ transplantation have been reported so far, in a renal transplant recipient, a pancreatic transplant recipient, and two liver transplant recipients 7,[12][13][14] (Table 1). We first describe a case of IMT of the liver following renal transplantation, which is also the second case of IMT after solid-organ transplantation localizing outside the allograft.…”

Section: Discussionmentioning

confidence: 99%

“…Hepatic IMT has been reported after bone marrow and liver transplantation. 6,7 Here, a case of IMT of the liver following renal transplantation was first reported that implicated immunosuppression as one possible underlying factor of these rare lesions. /L, carcinoembryonic antigen (CEA) 1.9 ng/mL (normal 0.00-5.00), and alphafetoprotein (AFP) 9.7 ng/mL (normal 0.00-25.00).…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Inflammatory Myofibroblastic Tumor of the Liver Following Renal Transplantation

et al. 2012

View full text Add to dashboard Cite

Inflammatory myofibroblastic tumor (IMT), previously named inflammatory pseudotumor, is a benign lesion, the exact etiology of which remains obscure; immunosuppression and infections have been speculated to be responsible for the development of pseudotumor. IMT associated with transplantation is rarely reported; we report the first case of IMT of the liver in a renal transplantation patient, who presented with symptoms of abdominal pain. The findings of computed tomography suggested hepatocellular carcinoma or liver abscess, and surgical resection was performed. The lesion was pathologically diagnosed as IMT.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Inflammatory Myofibroblastic Tumor of the Liver Following Renal Transplantation

et al. 2012

View full text Add to dashboard Cite

show abstract

“…9 Inflammatory myofibroblastic tumor after solid-organ transplant is rare and to the best of our knowledge, only 5 cases have been reported in the literature; the localizations of tumor were the pancreas, the colon, the liver (2), and the kidneys. [10][11][12][13][14] In our case, the IMT was detected in the lung almost 1 year after the liver transplant in a 2-year-old boy, and EBV positivity was noted in the spindle- …”

mentioning

confidence: 88%

Untitled

Tepeoğlu

Atılgan²,

Ozdemır³

et al. 2015

Exp Clin Transplant

View full text Add to dashboard Cite

Inflammatory myofibroblastic tumor is a rare benign lesion found mostly in children and young adults. It originates from the lung, abdominopelvic region, and retroperitoneum. The tumor is composed of myofibroblasts and inflammatory cell infiltration in the tissue. The cause and pathogenesis of this tumor are not completely understood. Epstein-Barr virus has been held responsible in some reported cases of inflammatory myofibroblastic tumors. Another tumor (which is known to be related to the Epstein-Barr virus) is posttransplant lymphoproliferative disorder.We report the case of a 2-year-old boy who underwent a liver transplant at the age of 9 months (the donor was his mother) because of biliary atresia. At 11 months after transplant, we detected posttransplant lymphoproliferative disorder and inflammatory myofibroblastic tumor concurrently. This entity is presented to highlight possible Epstein-Barr virus involvement in inflammatory myofibroblastic tumor of lung.

show abstract

“…1,7,[14][15][16][17][18][19] Use of CY is specifically mentioned as associated with bladder IPT in a recently published report. 10 All of the patients with IPT after HSCT were given high-dose chemotherapy and some also received TBI.…”

Section: Inflammatory Pseudotumor After Hsctmentioning

confidence: 99%

Inflammatory pseudotumor following hematopoietic stem cell transplantation: a new case and review of the literature

Bahat

Kalayoğlu-Beşışık

Öztürk

et al. 2007

Bone Marrow Transplant

View full text Add to dashboard Cite

Inflammatory pseudotumor (IPT) is a rare tumor that occurs in various organs and tissues. The clinical picture varies from the more frequent benign lesions to the rare malignant tumors with distant metastases. IPT associated with hematopoietic stem cell transplantation (HSCT) is rarely reported. In this article, we review the reports of IPT after HSCT and describe the first case of bladder IPT. We also review the possible factors involved in the pathogenesis. IPT might be rare but it is a potentially serious complication of HSCT. It should be considered in patients with otherwise unexplained inflammatory symptoms or signs or with any mass lesion in the post-HSCT period. A knowledge of this entity and insistence on a definitive biopsy of mass lesions in the post-HSCT period can avoid unnecessary treatment such as radical surgery, chemotherapy or radiotherapy.

show abstract

Inflammatory Pseudotumor After Liver Transplantation

Cited by 18 publications

References 9 publications

Inflammatory Myofibroblastic Tumor of the Liver Following Renal Transplantation

Inflammatory Myofibroblastic Tumor of the Liver Following Renal Transplantation

Untitled

Inflammatory pseudotumor following hematopoietic stem cell transplantation: a new case and review of the literature

Contact Info

Product

Resources

About